Clinical Trials Browser

OTHER × Carcinoma, Signet Ring Cell × Nivolumab × Clear all

NCT05504252 2026-01-07

METIMMOX-2

Phase 2 Active not recruiting

Adenocarcinoma, Mucinous, Carcinoma, Signet Ring Cell